SLI 3025288 / CH0030252883
2’110.59
Pkt
21.76
Pkt
1.04
%
15:39:30
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu SLI-Werten
| 25.04.23 | UBS Hold | Jefferies & Company Inc. | |
| 25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 25.04.23 | Nestlé Hold | Jefferies & Company Inc. | |
| 25.04.23 | ABB Buy | Goldman Sachs Group Inc. | |
| 25.04.23 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.04.23 | UBS Hold | Jefferies & Company Inc. | |
| 24.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 24.04.23 | Givaudan Sell | UBS AG | |
| 21.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 21.04.23 | Roche Sell | Deutsche Bank AG | |
| 21.04.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 19.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 19.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 19.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.23 | ABB Outperform | RBC Capital Markets | |
| 18.04.23 | Givaudan Underperform | Bernstein Research | |
| 17.04.23 | ABB Neutral | JP Morgan Chase & Co. | |
| 17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.04.23 | Givaudan Sell | UBS AG | |
| 17.04.23 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 14.04.23 | Givaudan Hold | Deutsche Bank AG | |
| 14.04.23 | Givaudan Underperform | Bernstein Research | |
| 13.04.23 | Richemont Buy | UBS AG | |
| 13.04.23 | Swiss Re Equal Weight | Barclays Capital | |
| 13.04.23 | Givaudan Underperform | Bernstein Research | |
| 13.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 13.04.23 | Givaudan Sell | UBS AG | |
| 13.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 12.04.23 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.04.23 | ABB Buy | UBS AG | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novartis Underweight | Barclays Capital | |
| 11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | ABB Equal Weight | Barclays Capital | |
| 06.04.23 | Zurich Insurance Buy | UBS AG |